EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Adoptively transferred Th17 cells cooperate with host B cells to achieve durable tumor immunity

Anna C Cole, Hannah M Knochelmann, Megan M Wyatt, Megen C Wittling, Natalie K Horvat, Aubrey S Smith, Guillermo O Rangel Rivera, Amalia M Rivera Reyes, Bhavana Pavuluri, Soundharya Kumaresan, Pawel Muranski, Ayana T Ruffin und 3 weitere

Cancer Cell · 2025-09 · 43 (9) · 1697-1713.e8

DOI: 10.1016/j.ccell.2025.07.001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Cell, 2025-09. Verfasst von Anna C Cole und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Winship Cancer Institute of Emory University, Atlanta, GA 30322, USA; Department of Microbiology and Immunology, Emory Univers…. Hauptthemen laut MEDLINE: Th17 Cells, B-Lymphocytes, Immunotherapy, Adoptive, Adoptive Transfer. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDCR NIH HHS, NCI NIH HHS, National Institutes of Health National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CD4+ T helper cells play an important role in adoptive T cell therapy (ACT) success, but it remains unclear which subset is most therapeutic and how they eliminate tumors. We find that tumor-specific Th17 cells eradicate melanoma more effectively than other CD4+ subsets and protect against distant metastases by unique orchestration of host immunity. Donor Th17 cells require host B cells -but not T cells- for tumor regression. Th17 cells induce B cell proliferation, activation, and differentiation, while B cells augment Th17 cell polyfunctionality by enhancing IL-21 production. Th17 and B cells colocalize in lymphoid tissues, where Th17 cells induce germinal centers and tumor-reactive antibodies via IL-21 production and CD40L costimulation. Furthermore, these tumor-specific antibodies provide partial protection against tumor challenge. Herein, we reveal that adoptively transferred Th17 cells cooperate with B cells to drive sustained immunity, demonstrating a role for endogenous B cell responses in effective CD4+ ACT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Th17 CellsB-LymphocytesImmunotherapy, AdoptiveAdoptive TransferMelanoma, ExperimentalAnimalsMiceMice, Inbred C57BLInterleukin-21Cell DifferentiationInterleukinsLymphocyte ActivationHumansCell Line, TumorGerminal Center

Stichwörter der Autor:innen

B cellsCD40IL-21Th17 celladoptive cell therapyantibodiescancer immunotherapygerminal centershumoral immunitymelanoma

Substanzen

Interleukin-21Interleukins

Autor:innen und Institutionen

  • Department of Surgery, Winship Cancer Institute of Emory University, Atlanta, GA 30322, USA; Department of Microbiology and Immunology, Emory University, Atlanta, GA 30322, USA. Electronic address: anna.cole@emory.edu.
  • Department of Surgery, Winship Cancer Institute of Emory University, Atlanta, GA 30322, USA; Department of Microbiology and Immunology, Emory University, Atlanta, GA 30322, USA; Department of Medicine, Stanford Universi…
  • Department of Surgery, Winship Cancer Institute of Emory University, Atlanta, GA 30322, USA; Department of Microbiology and Immunology, Emory University, Atlanta, GA 30322, USA.
  • Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA 30322, USA.
  • Department of Surgery, Winship Cancer Institute of Emory University, Atlanta, GA 30322, USA; Department of Microbiology and Immunology, Emory University, Atlanta, GA 30322, USA; Department of Microbiology and Immunology…
  • Columbia Center for Translational Immunology, Division of Hematology and Oncology, Columbia University Irving Medical Center, New York, NY 10032, USA.

Förderung

  • NIDCR NIH HHS
  • NCI NIH HHS
  • National Institutes of Health National Cancer Institute
  • Melanoma Research Foundation
  • Hollings Cancer Center, Medical University of South Carolina
  • V Foundation
  • National Institutes of Health
  • American Cancer Society

Zitieren

APA

Cole, A. C., Knochelmann, H. M., Wyatt, M. M., Wittling, M. C., Horvat, N. K., Smith, A. S., Rangel Rivera, G. O., Rivera Reyes, A. M., Pavuluri, B., Kumaresan, S., Muranski, P., Ruffin, A. T., Boss, J. M., Lesinski, G. B., & Paulos, C. M. (2025). Adoptively transferred Th17 cells cooperate with host B cells to achieve durable tumor immunity. Cancer Cell, 43(9), 1697-1713.e8. https://doi.org/10.1016/j.ccell.2025.07.001

Vancouver

Cole AC, Knochelmann HM, Wyatt MM, Wittling MC, Horvat NK, Smith AS, et al. Adoptively transferred Th17 cells cooperate with host B cells to achieve durable tumor immunity. Cancer Cell. 2025;43(9):1697-1713.e8. doi:10.1016/j.ccell.2025.07.001

BibTeX
@article{Cole2025,
  author = {Cole, Anna C and Knochelmann, Hannah M and Wyatt, Megan M and Wittling, Megen C and Horvat, Natalie K and Smith, Aubrey S and Rangel Rivera, Guillermo O and Rivera Reyes, Amalia M and Pavuluri, Bhavana and Kumaresan, Soundharya and Muranski, Pawel and Ruffin, Ayana T and Boss, Jeremy M and Lesinski, Gregory B and Paulos, Chrystal M},
  title = {Adoptively transferred Th17 cells cooperate with host B cells to achieve durable tumor immunity},
  journal = {Cancer Cell},
  year = {2025},
  volume = {43},
  number = {9},
  pages = {1697--1713.e8},
  doi = {10.1016/j.ccell.2025.07.001}
}
Kostenlos starten →